The technology, which will be used by Covidien’s respiratory and monitoring solutions business unit, reflects the company’s strong commitment to making investments in clinically relevant product innovations designed to improve patient outcomes.
CardioDigital’s innovative technology is expected to complement respiratory and monitoring solution’s Nellcor pulse oximetry platform.
Joe Almeida, president of medical devices at Covidien, said: “The acquisition of CardioDigital’s technology is an exciting opportunity for us to strengthen our patient monitoring business as we partner with our customers to improve outcomes.
“We believe that the technology will enable significant improvements in current patient monitoring techniques, resulting in enhanced patient care and safety.”